199800 — ToolGen Balance Sheet
0.000.00%
- KR₩315bn
- KR₩266bn
- KR₩891m
Annual balance sheet for ToolGen, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
R2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Interim Report | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 19,849 | 72,251 | 52,697 | 64,650 | 48,957 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 275 | 2,931 | 3,124 | 1,136 | 945 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 20,424 | 75,489 | 56,666 | 66,235 | 50,406 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 7,639 | 7,665 | 14,083 | 17,235 | 16,331 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 32,410 | 87,616 | 75,431 | 93,451 | 75,479 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1,061 | 1,985 | 3,859 | 1,771 | 15,640 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 2,520 | 2,953 | 4,962 | 63,356 | 17,043 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
ESOP Debt Guarantee | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 29,891 | 84,663 | 70,469 | 30,095 | 58,436 |
Total Liabilities & Shareholders' Equity | 32,410 | 87,616 | 75,431 | 93,451 | 75,479 |
Total Common Shares Outstanding |